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   Abstract:  
 
Pooling samples for serological testing was used first during the second world war. It was described later as a cost-
effective technique permitting large screening of populations, especially for new infectious diseases. However, the 
dilution effect is responsible for decreasing sensitivity, limiting its use in practice, especially blood banking. In this paper, 
we describe a modification of the classic enzyme-linked immunosorbent assay (ELISA) procedure, which permits the 
test of indefinite samples using just one well. Specimens are tested pure one by one without any dilution, so sensitivity 
remains unchanged. This new procedure is time-consuming but can be considered as a revolution in qualitative ELISA 
testing.  
 




ELISA testing was developed in the 1960s as a safety method to 
replace radioimmunologic assays. In the 80s, ELISA was 
generalized in all laboratories with the discovery of the human 
immunodeficiency virus. However, in the first times, the cost 
was high and couldn't be supported in low-income countries. 
Pooling sera for testing was considered a solution to reduce the 
cost of screening large populations; six to ten sera were mixed 
and tested. The negative result excluded the infection in all 
samples, while the positive reaction requires analyzing them 
one by one [1, 2]. Unfortunately, mixing sera shows to reduce 
the test's sensitivity, especially when diluting some low positive 
samples. In this case, the reactivity will be lower than the cutoff 
of detection [3, 4]. Thereby, Novack found a diminution of the 
sensitivity of detecting antigen S of B hepatitis from 99% to 
93% when pooling and an extension of the serological windows 
for five days [5]. In another study, Novack also found a 
reduction of the sensitivity by 3% to detect antibodies of C 
hepatitis when using a pool of 6 samples [6]. In addition to the 
effect of dilution, there is a risk of neutralization of antigens 
such as antigen S of B hepatitis when mixed with sera 
containing antibodies against antigen S [5]. For these reasons, 
pooling was prohibited in blood banking, even in developing  
 
 
countries [7]. We presented a modification of the procedure of 
qualitative ELISA permitting testing theoretically an infinite 
number of samples using just one well. 
 
Presentation of the hypothesis 
In ELISA testing, wells are coated with an antibody (or antigen 
for sandwich ELISA), forming a solid phase [8]. In the first 
step, the sample is added, and the eventual antigen (or antibody) 
presents in sera will set to the solid phase. After washing, this 
reaction will be completed by the addition of a conjugate 
containing an antibody (or antigen) associated with a specific 
enzyme such as alkaline phosphatase (EC 3.1.3.1) or glucose 
oxidase (EC 1.1.3.4). This enzyme catalysis a colorimetric 
reaction, which means a positive reaction.      
     The proposed idea consists of the incubation in one well of 
samples one after one before washing and adding conjugate.  
In the first step, a sample is incubated, and in the second step, 
the first sample is eliminated from the well, and a second sera is 
added for incubation. These operations can be repeated many 
times (eliminating sera and incubation of a new one in the same 
well). 
     If one of the multiple samples tested contains the specific 
antibody (or antigen), it will be irreversibly fixed in the solid 
phase even if all other samples are negatives. The procedure is 
completed without modifications with washing, the addition of 
conjugate followed by colorimetric revelation. 
___________________________________________________ 
benazim@ymail.com 
1Department of Hemobiology, EHU "1er Novembre 1954", Oran, Algeria. 
Faculty of Medicine, University of Oran 1 Ahmed Ben Bella, Algeria. 
 
Full list of author information is available at the end of the article 
 
                                           Bennaoum MN, et al., Journal of Ideas in Health (2020); 3(Special 2):275-277                                                   277  
 
A positive reaction means that at least one of the samples is 
reactive and impose analyzing them one by one or by smaller 
groups. 
 
Evaluation of the procedure 
To be validated, this method must present the same sensitivity 
as classical ELISA testing. For evaluating this procedure, 
positive control, or a known positive sample (confirmed 
containing antibodies or antigens of an infectious disease) 
should be tested first and followed by a series of known 
negatives sera in the same well as described above. In the end, 
the reaction must be positive. 
     The sensitivity of this new procedure can also be evaluated 
and compared to classical methods. For this, the positive sample 
should be diluted half to half (1⁄2, 1⁄4, 1/8, 1/16, 1/32…). Each 
dilution is tested in duplicate with classical ELISA and with the 
proposed procedure. The last dilutions giving a positive reaction 
with the two methods are compared and must be the same.    
 
Consequences of the idea 
The main disadvantage of pooling sera is the dilution effect as 
described above. The proposed procedure permits to test of pure 
samples, so the sensitivity remains unchanged and avoids 
antigens' neutralization. Successive incubations of samples are 
time-consuming, but the financial benefit is significant.  
     This hypothesis's benefit is also important, for example, 
during the first times of a pandemic, especially with new 
emerging infectious diseases. In these situations, the need for 
screening tests exceeds their production rate. This has been 
observed in the 80s with the apparition of the acquired 
immunodeficiency disease syndrome and, more recently, with 
the severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) [9]. The other benefit is economic; this hypothesis's 
application permits a drastic reduction in screening populations' 
cost, particularly in low-income countries.    
 
Conclusion  
Incubating samples one by one in ELISA testing, as described 
in this paper, seems to be a real alternative to pooling sera 




ELISA: Enzyme-Linked Immunosorbent Assay; SARS-CoV-2: Severe 
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